Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
01/2011
01/12/2011CN101941985A Anthanthrene based compound and semiconductor device
01/12/2011CN101497623B Compound containing imidazopyridine
01/12/2011CN101492464B Sulfhydryl imidazopyridine derivative containing dioxepane-pyridine
01/12/2011CN101492463B Imidazopyridine derivative containing dioxane-pyridine
01/11/2011US7868002 Deazapurines and uses thereof
01/11/2011CA2538032C Thienopyrazoles
01/11/2011CA2503371C Quinazoline derivatives as src tyrosine kinase inhibitors
01/11/2011CA2451678C Azaindoles
01/05/2011EP2270010A1 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins
01/05/2011EP2268280A2 Quinolizidinone m1 receptor positive allosteric modulators
01/05/2011CN101939324A Pyrrolopyrazine kinase inhibitors
01/05/2011CN101939323A Pyrazolopyrimidines, a process for their preparation and their use as medicine
01/05/2011CN101935321A Method for synthesizing 1 beta methyl carbapenem antibiotic
01/05/2011CN101935303A Broadspectrum substituted benzimidazole sulfonamide HIV protease inhibitors
01/04/2011CA2377671C High density non-volatile memory device
12/2010
12/30/2010US20100331355 Substituted Quinolines for the Treatment of Cancer
12/30/2010US20100330030 Vasculostatic Agents and Methods of Use Thereof
12/29/2010WO2010150593A1 Organic electroluminescent element, display device, illuminating device and condensed polycyclic heterocyclic compound
12/29/2010EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
12/29/2010EP2265607A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
12/29/2010EP1560827B1 Anti-infective agents
12/29/2010CN101928293A Bisindole alkaloid compound, medicine composition thereof and preparation method and application of medicine composition
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010054278A3 Compounds for the treatment of inflammatory disorders
12/23/2010US20100324288 Dihydropteridinone Compounds
12/22/2010EP2001894B1 Novel bis-2-difluoro-pyrrolo[2,1-c][1,4]benzodiazepine dimmers
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN101921238A Preparation of substituted nitrogen-containing benzoheterocycle derivatives and pharmacological application thereof
12/22/2010CN101423524B Diglutamate derivates and application thereof in preparation of pemetrexed
12/22/2010CN101302227B Method for synthesizing 3,3'-purrocoline compounds
12/22/2010CN101029276B Fast method for continuouslly extracting nim oil and nimbin raw medicine from nim seed
12/21/2010US7855294 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
12/16/2010CA2847910A1 Anti-viral compounds
12/15/2010EP2261226A1 Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase
12/15/2010EP1984366B1 3, 9-diazabicyclo ý3.3. 1¨nonane derivatives and their use as monoamine?neurotransmitter re-uptake inhibitors
12/15/2010EP1756104B1 Tetrahydronaphthyridine derivatives useful as histamine h3 receptor ligands
12/15/2010CN101918412A Cyclopropyl fused indolobenzazepine derivatives for the treatment of hepatitis c
12/15/2010CN101918407A Beta-lactamase inhibitors
12/15/2010CN101914099A Covalently linked oligonucleotide minor groove binder conjugates
12/15/2010CN101357929B Cephalosporin derivative containing sulfhydryl thiadiazole
12/14/2010US7851468 Substituted pyrazolo[3,4-d]pyrimidines
12/14/2010CA2355939C Antihistaminic spiro compounds
12/09/2010WO2010139717A1 New compounds
12/09/2010US20100311721 Compounds
12/08/2010EP2259068A2 Capture compounds and methods for analyzing the proteome
12/08/2010EP2258704A1 Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
12/08/2010EP2258682A2 Amino-substituted tricyclic derivatives and methods of use
12/08/2010EP2257551A2 Azatricyclic antibiotic compounds
12/08/2010CN101910184A Solubilized thiazolopyridines
12/08/2010CN101910169A Bicycloamine derivative
12/08/2010CN101362771B Method for preparing high purity vincristine sulfate
12/07/2010US7846931 Pyrrolotriazine compounds as kinase inhibitors
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010136778A1 Dibenzothiophene derivatives as dna- pk inhibitors
12/02/2010WO2010136438A1 (dihydro) imidazoiso (5, 1-a) quinolines as fsh receptor agonists for the treatment of fertility disorders
12/02/2010US20100305114 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/02/2010CA2763118A1 (dihydro) imidazoiso (5, 1-a)quinolines as fsh receptor agonists for the treatment of fertility disorders
12/01/2010EP2254887A1 Oxazolidinone derivatives
12/01/2010EP2254413A1 Imidazobenzazepine cgrp receptor antagonists
12/01/2010CN101899059A Pyrrolidine-containing dicyclic cephalosporin derivatives
12/01/2010CN101386625B Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer
11/2010
11/30/2010US7842808 Anti-migraine spirocycles
11/30/2010US7842802 Vinorelbine derivatives
11/30/2010CA2497868C Heterocyclic compounds
11/30/2010CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor
11/25/2010WO2010135524A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010CA2763099A1 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252616A1 Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
11/24/2010EP2252151A1 Quinolizidinone m1 receptor positive allosteric modulators
11/24/2010EP1603917B1 Immunomodulating heterocyclic compounds
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010EP1549156B1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it
11/24/2010EP1497287B1 Quinoline derivatives in combination with 5-FU or CPT-11 for use in the treatment of cancer
11/24/2010CN101891756A Synthesis method of biapenem ester
11/24/2010CN101074233B 4'-demethylpodoph-yllotoxin derivative, its production and use
11/23/2010US7838528 Substituted bicyclic 8-pyrrolidinoxanthines, methods for their production, pharmaceutical formulations and their use
11/23/2010US7838517 Compounds useful as protein kinase inhibitors
11/23/2010US7838299 use of the complexes obtained as fluorescent markers, and as relaxation agents for NMR or for NMR imaging
11/23/2010CA2503223C Meso-substituted porphyrins
11/23/2010CA2440014C Beta-carboline derivatives and its pharmaceutical use against depression and anxiety
11/23/2010CA2423192C 1-azabicyclo[2.2.2]octan-3-one derivatives and maleimide derivatives and their use for treating cancer tumors
11/18/2010WO2010132599A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010130840A1 Triazole/tetrazole polymers resulting from the cycloaddition of functionalized monomers derived from dianhydrohexitol, intermediate compounds, methods of preparing same and applications thereof
11/18/2010WO2010130424A1 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/18/2010WO2010130422A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/18/2010US20100292196 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors
11/18/2010CA2761881A1 Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene a4 hydrolase
11/18/2010CA2760741A1 1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
11/18/2010CA2760259A1 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
11/17/2010EP2251343A1 Imidazothiazoles as p38-kinase-inhibitors
11/17/2010EP2249830A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010EP2249647A1 Dual pharmacophores - pde4-muscarinic antagonistics
11/17/2010EP2054421B1 Pyrazolopyrimidines, a process for their preparation and their use as medicine
11/17/2010CN101343282B Cephalosporin derivatives containing condensed nucleus
11/16/2010US7834014 Parkinson's disease; [2-(7-amino-2-furan-2-yl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)-octahydro-pyrido[1,2-a]pyrazin-7-yl]-methanol;
11/10/2010EP2247598A1 Substituted heteroarylamide oxazepinopyrimidone derivatives
11/10/2010EP2247595A1 Pyrrolopyrazine kinase inhibitors
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 111